Early Access to Virtual Resources for the Self-management of Plantar Fasciitis (EASE-P)

February 8, 2023 updated by: Cardiff and Vale University Health Board

Early Access to Virtual Resources for the Self-management of Plantar Fasciitis: A Proof of Concept and Feasibility Study

This proof of concept and feasibility study will adopt a mixed methods approach. The primary objectives will be to assess participants' acceptance and usability of a package of self-help videos for Plantar Fasciitis designed to be accessed shortly after suitable participants are referred to the podiatry service, and also the feasibility of conducting a future randomised controlled trial. The secondary objectives will be to assess the effects of the intervention on pain and quality of life.

Study Overview

Status

Completed

Conditions

Detailed Description

This proof of concept and feasibility project will investigate the use of a self-help package of virtual resources for the treatment of plantar fasciitis. The research will involve a small group of ten, shortly after participants are referred to Cardiff & Vale UHB podiatry service and join the waiting list.

The virtual resources will include short videos demonstrating ways of managing symptoms, such as gentle stretching exercises, and footwear recommendations. Participants will be given access to these resources to watch at their convenience. Patient reported outcome measures (foot pain, and quality of life) will be collated at baseline and periodically up to 6 weeks. Participants' acceptability of these resources will be assessed through interviews at the end of the six weeks.

The feasibility of conducting a future randomised controlled trial will be assessed by looking at recruitment rates, retention and any patient safety issues. It is hoped the long term benefit will be that participants joining the waiting list can engage with these resources at the earliest opportunity to help manage their symptoms.

This research is important because it presents an opportunity to work with participants at the start of joining a waiting list, and the benefits of early access to virtual resources could be applicable to a number of different health problems.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cardiff, United Kingdom, CF14 4XW
        • Clinical Research Facility

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

-

Inclusion Criteria:

  • Diagnosis of Plantar Fasciitis by assessing podiatrist:
  • Plantar medial heel pain: most noticeable with initial steps after a period of inactivity (post static dyskinesia) but also worse following prolonged weight bearing
  • Pain with palpation of the proximal insertion of the plantar fascia, most commonly the medial calcaneal tubercle, the site of the plantar aponeurosis (Clinical pressure application to locate the most tender spot in order to anatomically describe the site).
  • Symptomatic for PF for any time period
  • ≥18 years of age
  • Able to provide informed consent
  • Access to internet

Exclusion Criteria:

  • Diabetes or neuropathy
  • History of systemic diseases such as inflammatory joint disease, rheumatic, autoimmune or neurological conditions.
  • Chronic pain syndrome or lumbosacral radiculitis
  • Pregnancy
  • Orthopaedic surgery (spinal/ lower limb within the last year)
  • Corticosteroid injection for plantar fasciitis in the last 6 months (prior to onset)
  • Plantar heel pain related to fractures, tumours, infection, nerve entrapment or in the opinion of the assessing podiatrist confounded by any other medical condition
  • Patient unable to complete exercises in self-help resources
  • Unable to access internet

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Videos
Single Arm study: All participants recruited to the study will be allocated to a single arm- "videos" in which participants will be able to access self help videos for plantar fasciitis
Single arm study. Participants are given access to self help videos for the management of plantar fasciitis while they are on the waiting list

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability of resources as assessed through semi structured interviews
Time Frame: 6 weeks
End of study semi-structured interviews, analysed using a thematic approach.
6 weeks
Usability of resources as assessed through semi structured interviews
Time Frame: 6 weeks
End of study semi-structured interviews, analysed using a thematic approach
6 weeks
Feasibility as assessed through recruitment and retention rates
Time Frame: 6 weeks
End of study assessment of feasibility through recruitment and retention rates.
6 weeks
Feasibility as assessed through adverse events.
Time Frame: 6 weeks
End of study assessment of feasibility through adverse events
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess effects of intervention on pain using Visual Analogue Scale with higher scores indicating a worse outcome
Time Frame: 6 weeks
Patient reported outcome measures recorded at baseline, 2 4 and 6 weeks
6 weeks
Assess effects of intervention on quality of life using EQ5D (EuroQol) with higher scores indicating a worse outcome
Time Frame: 6 weeks
Patient reported outcome measures at baseline, 2 4 and 6 weeks
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 27, 2021

Primary Completion (ACTUAL)

July 4, 2022

Study Completion (ACTUAL)

July 4, 2022

Study Registration Dates

First Submitted

August 3, 2021

First Submitted That Met QC Criteria

October 5, 2021

First Posted (ACTUAL)

October 8, 2021

Study Record Updates

Last Update Posted (ESTIMATE)

February 9, 2023

Last Update Submitted That Met QC Criteria

February 8, 2023

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 8125

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plantar Fascitis

Clinical Trials on Early access to virtual resources

Subscribe